Embryonic folate metabolism and mouse neural tube defects

Area of Science:

• Developmental biology
• Nutritional science
• Genetics

Background:

• Neural tube defects (NTDs) are common birth defects, with folic acid known to prevent 70% of cases.
• The precise mechanism by which folic acid prevents NTDs remains largely unknown.
• The splotch (Pax3) mouse model exhibits NTDs and provides an in vitro system to study folate metabolism.

Purpose of the Study:

• To investigate the metabolic role of folic acid in preventing neural tube defects.
• To elucidate the mechanism of action of folic acid in embryonic development.
• To utilize the splotch mouse model to understand folate metabolism disturbances.

Main Methods:

• Employing the deoxyuridine suppression test to assess folate metabolism in splotch mouse embryos.
• Measuring the incorporation of [3H]thymidine to detect metabolic deficiencies.
• Administering exogenous folic acid, thymidine, and methionine to observe their effects on NTDs and metabolism.

Main Results:

• Splotch mouse embryos show disturbed folate metabolism and excessive [3H]thymidine incorporation, indicating a pyrimidine biosynthesis defect.
• Exogenous folic acid and thymidine corrected the metabolic defect and reduced NTDs in splotch homozygotes.
• Methionine exacerbated the metabolic defect and increased NTD incidence in splotch homozygotes.

Conclusions:

• Folic acid directly normalizes neurulation, suggesting a metabolic basis for its preventative action against NTDs in humans.
• Disruptions in folate metabolism are directly linked to the development of neural tube defects.
• Thymidine plays a role in correcting folate-related metabolic deficiencies during embryonic development.